{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:35:38Z","timestamp":1781033738207,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>EUROCRINE is an endocrine surgical register documenting diagnostic processes, indication for surgical treatment, surgical procedures, and outcomes. The purpose was to analyse data for PHPT in German speaking countries regarding differences in clinical presentation, diagnostic workup, and treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>All operations for PHPT performed from 07\/2015 to 12\/2019 were analysed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three thousand two hundred ninety-one patients in Germany (9 centres; 1762 patients), Switzerland (16 centres; 971 patients) and Austria (5 centres; 558 patients) were analysed. Hereditary disease was seen in 36 patients in Germany, 16 patients in Switzerland and 8 patients in Austria. In sporadic disease before primary operation, PET-CT showed the highest sensitivity in all countries. In re-operations, CT and PET-CT achieved the highest sensitivities. The highest sensitivity of IOPTH was seen in Austria (98.1%), followed by Germany (96.4%) and Switzerland (91.3%). Operation methods and mean operative time reached statistical significance (<jats:italic>p<\/jats:italic>&lt;0.05). Complication rates are low. Overall, 656 (19.9%) patients were asymptomatic; the remainder showed bone manifestations, kidney stones, fatigue and\/or neuropsychiatric symptoms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Early postoperative normocalcaemia ranged between 96.8 and 97.1%. Complication rates are low. PET-CT had the highest sensitivity in all three countries in patients undergoing primary operation as well as in Switzerland and Austria in patients undergoing re-operation. PET-CT could be considered a first-line preoperative imaging modality in patients with inconclusive ultrasound examination. The EUROCRINE registry is a beneficial and comprehensive data source for outcome analysis of endocrine procedures on a supranational level.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00423-023-02819-2","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T18:03:09Z","timestamp":1681408989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Surgery for primary hyperparathyroidism in Germany, Switzerland, and Austria: an analysis of data from the EUROCRINE registry"],"prefix":"10.1007","volume":"408","author":[{"given":"L.","family":"Hargitai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. J.","family":"Musholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Riss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the EUROCRINE council","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,13]]},"reference":[{"key":"2819_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","volume":"28","author":"AA Khan","year":"2017","unstructured":"Khan AA, Hanley DA, Rizzoli R et al (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1\u201319. https:\/\/doi.org\/10.1007\/s00198-016-3716-2","journal-title":"Osteoporos Int"},{"key":"2819_CR2","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1210\/jc.2014-2000","volume":"99","author":"R Udelsman","year":"2014","unstructured":"Udelsman R, Akerstrom G, Biagini C et al (2014) The surgical management of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. The Journal of clinical endocrinology and metabolism 99:3595\u20133606. https:\/\/doi.org\/10.1210\/jc.2014-2000","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"2819_CR3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/bjs.12025","volume":"108","author":"A Bergenfelz","year":"2020","unstructured":"Bergenfelz A, van Slycke S, Makay O et al (2020) European multicentre study on outcome of surgery for sporadic primary hyperparathyroidism. The British journal of surgery. 108:675\u2013683. https:\/\/doi.org\/10.1002\/bjs.12025","journal-title":"The British journal of surgery."},{"key":"2819_CR4","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00423-009-0533-5","volume":"394","author":"AO Bergenfelz","year":"2009","unstructured":"Bergenfelz AO, Hellman P, Harrison B et al (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761\u2013764. https:\/\/doi.org\/10.1007\/s00423-009-0533-5","journal-title":"Langenbecks Arch Surg"},{"key":"2819_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1001\/archsurg.1994.01420320096019","volume":"129","author":"JM Rodriquez","year":"1994","unstructured":"Rodriquez JM, Tezelman S, Siperstein AE et al (1994) Localization procedures in patients with persistent or recurrent hyperparathyroidism. Arch Surg 129:870\u2013875. https:\/\/doi.org\/10.1001\/archsurg.1994.01420320096019","journal-title":"Arch Surg"},{"key":"2819_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1365-2265.2006.02556.x","volume":"65","author":"M Barczynski","year":"2006","unstructured":"Barczynski M, Golkowski F, Konturek A et al (2006) Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clinical endocrinology 65:106\u2013113. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02556.x","journal-title":"Clinical endocrinology"},{"key":"2819_CR7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00423-009-0534-4","volume":"394","author":"R Mihai","year":"2009","unstructured":"Mihai R, Simon D, Hellman P (2009) Imaging for primary hyperparathyroidism--an evidence-based analysis. Langenbecks Arch Surg 394:765\u2013784. https:\/\/doi.org\/10.1007\/s00423-009-0534-4","journal-title":"Langenbecks Arch Surg"},{"key":"2819_CR8","first-page":"241","volume":"153","author":"QY Duh","year":"1987","unstructured":"Duh QY, Sancho JJ, Clark OH (1987) Parathyroid localization. Clinical review. Acta Chir Scand 153:241\u2013254","journal-title":"Clinical review. Acta Chir Scand"},{"key":"2819_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/s0001-2998(87)80026-0","volume":"17","author":"EJ Fine","year":"1987","unstructured":"Fine EJ (1987) Parathyroid imaging: its current status and future role. Semin Nucl Med 17:350\u2013359. https:\/\/doi.org\/10.1016\/s0001-2998(87)80026-0","journal-title":"Semin Nucl Med"},{"key":"2819_CR10","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.semnuclmed.2005.06.001","volume":"35","author":"CJ Palestro","year":"2005","unstructured":"Palestro CJ, Tomas MB, Tronco GG (2005) Radionuclide imaging of the parathyroid glands. Semin Nucl Med 35:266\u2013276. https:\/\/doi.org\/10.1053\/j.semnuclmed.2005.06.001","journal-title":"Semin Nucl Med"},{"key":"2819_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/MNM.0000000000000262","volume":"36","author":"KK Wong","year":"2015","unstructured":"Wong KK, Fig LM, Gross MD et al (2015) Parathyroid adenoma localization with 99mTc-sestamibi SPECT\/CT: a meta-analysis. Nucl Med Commun 36:363\u2013375. https:\/\/doi.org\/10.1097\/MNM.0000000000000262","journal-title":"Nucl Med Commun"},{"key":"2819_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s00423-022-02442-7","volume":"407","author":"L Hargitai","year":"2022","unstructured":"Hargitai L, Schefner M, Traub-Weidinger T et al (2022) Accessing the influence of (99m)Tc-Sesta-MIBI-positive thyroid nodules on preoperative localisation studies in patients with primary hyperparathyroidism. Langenbecks Arch Surg. 407:1183\u20131191. https:\/\/doi.org\/10.1007\/s00423-022-02442-7","journal-title":"Langenbecks Arch Surg."},{"key":"2819_CR13","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.21037\/gs.2019.11.10","volume":"9","author":"B Wojtczak","year":"2020","unstructured":"Wojtczak B, Syrycka J, Kaliszewski K et al (2020) Surgical implications of recent modalities for parathyroid imaging. Gland Surg 9:S86\u2013S94. https:\/\/doi.org\/10.21037\/gs.2019.11.10","journal-title":"Gland Surg"},{"key":"2819_CR14","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1007\/s00268-015-2992-x","volume":"39","author":"C Lenschow","year":"2015","unstructured":"Lenschow C, Gassmann P, Wenning C et al (2015) Preoperative (1)(1)C-methionine PET\/CT enables focused parathyroidectomy in MIBI-SPECT negative parathyroid adenoma. World journal of surgery 39:1750\u20131757. https:\/\/doi.org\/10.1007\/s00268-015-2992-x","journal-title":"World journal of surgery"},{"key":"2819_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/dc.24065","volume":"47","author":"C Aydin","year":"2019","unstructured":"Aydin C, Polat SB, Dellal FD et al (2019) The diagnostic value of parathyroid hormone washout in primary hyperparathyroidism patients with negative or equivocal 99 m Tc-MIBI results. Diagn Cytopathol 47:94\u201399. https:\/\/doi.org\/10.1002\/dc.24065","journal-title":"Diagn Cytopathol"},{"key":"2819_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jamasurg.2013.57","volume":"148","author":"CA Madorin","year":"2013","unstructured":"Madorin CA, Owen R, Coakley B et al (2013) Comparison of radiation exposure and cost between dynamic computed tomography and sestamibi scintigraphy for preoperative localization of parathyroid lesions. JAMA Surg 148:500\u2013503. https:\/\/doi.org\/10.1001\/jamasurg.2013.57","journal-title":"JAMA Surg"},{"key":"2819_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/MNM.0000000000000952","volume":"40","author":"WAM Broos","year":"2019","unstructured":"Broos WAM, van der Zant FM, Knol RJJ et al (2019) Choline PET\/CT in parathyroid imaging: a systematic review. Nucl Med Commun 40:96\u2013105. https:\/\/doi.org\/10.1097\/MNM.0000000000000952","journal-title":"Nucl Med Commun"},{"key":"2819_CR18","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1007\/s00259-018-3980-9","volume":"45","author":"M Beheshti","year":"2018","unstructured":"Beheshti M, Hehenwarter L, Paymani Z et al (2018) (18)F-fluorocholine PET\/CT in the assessment of primary hyperparathyroidism compared with (99m)Tc-MIBI or (99m)Tc-tetrofosmin SPECT\/CT: a prospective dual-centre study in 100 patients. Eur J Nucl Med Mol Imaging 45:1762\u20131771. https:\/\/doi.org\/10.1007\/s00259-018-3980-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2819_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2967\/jnumed.121.261900","volume":"63","author":"V Boudousq","year":"2021","unstructured":"Boudousq V, Guignard N, Gilly O et al (2021) Diagnostic performances of cervical ultrasound, sestamibi scintigraphy and contrast-enhanced (18)F-fluorocholine positron emission tomography in primary hyperparathyroidism. J Nucl Med. 63:1081\u20131086. https:\/\/doi.org\/10.2967\/jnumed.121.261900","journal-title":"J Nucl Med."},{"key":"2819_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1097\/MNM.0000000000000899","volume":"39","author":"M Araz","year":"2018","unstructured":"Araz M, Soydal C, Ozkan E et al (2018) The efficacy of fluorine-18-choline PET\/CT in comparison with 99mTc-MIBI SPECT\/CT in the localization of a hyperfunctioning parathyroid gland in primary hyperparathyroidism. Nucl Med Commun 39:989\u2013994. https:\/\/doi.org\/10.1097\/MNM.0000000000000899","journal-title":"Nucl Med Commun"},{"key":"2819_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.119.229914","volume":"61","author":"A Cuderman","year":"2020","unstructured":"Cuderman A, Senica K, Rep S et al (2020) (18)F-Fluorocholine PET\/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands. J Nucl Med 61:577\u2013583. https:\/\/doi.org\/10.2967\/jnumed.119.229914","journal-title":"J Nucl Med"},{"key":"2819_CR22","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1097\/MNM.0000000000000924","volume":"39","author":"M Prabhu","year":"2018","unstructured":"Prabhu M, Kumari G, Damle NA et al (2018) Assessment of the role of early dynamic PET\/CT with 18F-fluorocholine in detection of parathyroid lesions in patients with primary hyperparathyroidism. Nucl Med Commun 39:1190\u20131196. https:\/\/doi.org\/10.1097\/MNM.0000000000000924","journal-title":"Nucl Med Commun"},{"key":"2819_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1088\/1361-6498\/aaa86f","volume":"38","author":"S Rep","year":"2018","unstructured":"Rep S, Hocevar M, Vaupotic J et al (2018) (18)F-choline PET\/CT for parathyroid scintigraphy: significantly lower radiation exposure of patients in comparison to conventional nuclear medicine imaging approaches. J Radiol Prot 38:343\u2013356. https:\/\/doi.org\/10.1088\/1361-6498\/aaa86f","journal-title":"J Radiol Prot"},{"key":"2819_CR24","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1097\/RLU.0000000000001845","volume":"42","author":"N Thanseer","year":"2017","unstructured":"Thanseer N, Bhadada SK, Sood A et al (2017) Comparative Effectiveness of ultrasonography, 99mTc-Sestamibi, and 18F-fluorocholine PET\/CT in detecting parathyroid adenomas in patients with primary hyperparathyroidism. Clin Nucl Med 42:e491\u2013e497. https:\/\/doi.org\/10.1097\/RLU.0000000000001845","journal-title":"Clin Nucl Med"},{"key":"2819_CR25","first-page":"A8840","volume":"159","author":"WP Kluijfhout","year":"2015","unstructured":"Kluijfhout WP, Vriens MR, Borel Rinkes IH et al (2015) 18F-fluorocholine PET-CT for localization of parathyroid adenomas. Ned Tijdschr Geneeskd 159:A8840","journal-title":"Ned Tijdschr Geneeskd"},{"key":"2819_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s40618-018-0931-z","volume":"42","author":"I Bossert","year":"2019","unstructured":"Bossert I, Chytiris S, Hodolic M et al (2019) PETC\/CT with (18)F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism. Journal of endocrinological investigation 42:419\u2013426. https:\/\/doi.org\/10.1007\/s40618-018-0931-z","journal-title":"Journal of endocrinological investigation"},{"key":"2819_CR27","doi-asserted-by":"publisher","unstructured":"Silva BC, Cusano NE, Bilezikian JP (2018) Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32:593\u2013607. https:\/\/doi.org\/10.1016\/j.beem.2018.09.013","DOI":"10.1016\/j.beem.2018.09.013"},{"key":"2819_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12688\/f1000research.7039.1","volume":"5","author":"L Bandeira","year":"2016","unstructured":"Bandeira L, Bilezikian J (2016) Primary Hyperparathyroidism. F1000Res 5 5:1. https:\/\/doi.org\/10.12688\/f1000research.7039.1","journal-title":"F1000Res 5"},{"key":"2819_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","volume":"280","author":"RV Thakker","year":"2016","unstructured":"Thakker RV (2016) Genetics of parathyroid tumours. J Intern Med 280:574\u2013583. https:\/\/doi.org\/10.1111\/joim.12523","journal-title":"J Intern Med"},{"key":"2819_CR30","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1210\/jc.2015-2022","volume":"100","author":"MD Walker","year":"2015","unstructured":"Walker MD, Cong E, Lee JA et al (2015) Vitamin D in primary hyperparathyroidism: effects on clinical, biochemical, and densitometric presentation. The Journal of clinical endocrinology and metabolism 100:3443\u20133451. https:\/\/doi.org\/10.1210\/jc.2015-2022","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"2819_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s12020-016-0931-8","volume":"55","author":"G Viccica","year":"2017","unstructured":"Viccica G, Cetani F, Vignali E et al (2017) Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 55:256\u2013265. https:\/\/doi.org\/10.1007\/s12020-016-0931-8","journal-title":"Endocrine"},{"key":"2819_CR32","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1001\/2013.jamasurg.316","volume":"148","author":"T Weber","year":"2013","unstructured":"Weber T, Eberle J, Messelhauser U et al (2013) Parathyroidectomy, elevated depression scores, and suicidal ideation in patients with primary hyperparathyroidism: results of a prospective multicenter study. JAMA Surg 148:109\u2013115. https:\/\/doi.org\/10.1001\/2013.jamasurg.316","journal-title":"JAMA Surg"},{"key":"2819_CR33","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1177\/000313481608200948","volume":"82","author":"JY Liu","year":"2016","unstructured":"Liu JY, Saunders ND, Chen A et al (2016) Neuropsychological changes in primary hyperparathyroidism after parathyroidectomy. Am Surg 82:839\u2013845","journal-title":"Am Surg"},{"key":"2819_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.surg.2015.03.054","volume":"158","author":"K Zanocco","year":"2015","unstructured":"Zanocco K, Butt Z, Kaltman D et al (2015) Improvement in patient-reported physical and mental health after parathyroidectomy for primary hyperparathyroidism. Surgery 158:837\u2013845. https:\/\/doi.org\/10.1016\/j.surg.2015.03.054","journal-title":"Surgery"},{"key":"2819_CR35","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1210\/jc.2011-0569","volume":"96","author":"L Rejnmark","year":"2011","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2011) Nephrolithiasis and renal calcifications in primary hyperparathyroidism. The Journal of clinical endocrinology and metabolism 96:2377\u20132385. https:\/\/doi.org\/10.1210\/jc.2011-0569","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"2819_CR36","doi-asserted-by":"publisher","first-page":"CD010787","DOI":"10.1002\/14651858.CD010787.pub2","volume":"10","author":"H Ahmadieh","year":"2020","unstructured":"Ahmadieh H, Kreidieh O, Akl EA et al (2020) Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults. Cochrane Database Syst Rev 10:CD010787. https:\/\/doi.org\/10.1002\/14651858.CD010787.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2819_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1072-7515(03)00676-8","volume":"197","author":"M Haciyanli","year":"2003","unstructured":"Haciyanli M, Lal G, Morita E et al (2003) Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma. J Am Coll Surg 197:739\u2013746. https:\/\/doi.org\/10.1016\/S1072-7515(03)00676-8","journal-title":"J Am Coll Surg"},{"key":"2819_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1055\/a-1018-2767","volume":"145","author":"KM Derwahl","year":"2020","unstructured":"Derwahl KM, Goretzki P (2020) Thyroid nodules: the guidelines of the American Thyroid Association from a European perspective. Dtsch Med Wochenschr 145:1227\u20131235. https:\/\/doi.org\/10.1055\/a-1018-2767","journal-title":"Dtsch Med Wochenschr"},{"key":"2819_CR39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/BF02067325","volume":"16","author":"PE Goretzki","year":"1992","unstructured":"Goretzki PE, Lyons J, Stacy-Phipps S et al (1992) Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World journal of surgery 16:576\u2013581. https:\/\/doi.org\/10.1007\/BF02067325","journal-title":"World journal of surgery"},{"key":"2819_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1001\/archsurg.137.2.186","volume":"137","author":"J Westerdahl","year":"2002","unstructured":"Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186\u2013190. https:\/\/doi.org\/10.1001\/archsurg.137.2.186","journal-title":"Arch Surg"},{"key":"2819_CR41","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.surg.2005.06.046","volume":"138","author":"H Chen","year":"2005","unstructured":"Chen H, Pruhs Z, Starling JR et al (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583\u2013587. https:\/\/doi.org\/10.1016\/j.surg.2005.06.046","journal-title":"Surgery"},{"key":"2819_CR42","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/archsurg.140.5.472","volume":"140","author":"CS Grant","year":"2005","unstructured":"Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472\u2013478. https:\/\/doi.org\/10.1001\/archsurg.140.5.472","journal-title":"Arch Surg"},{"key":"2819_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00423-009-0505-9","volume":"394","author":"P Riss","year":"2009","unstructured":"Riss P, Scheuba C, Asari R et al (2009) Is minimally invasive parathyroidectomy without QPTH monitoring justified? Langenbecks Arch Surg 394:875\u2013880. https:\/\/doi.org\/10.1007\/s00423-009-0505-9","journal-title":"Langenbecks Arch Surg"},{"key":"2819_CR44","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.1245\/s10434-016-5241-0","volume":"23","author":"SC Oltmann","year":"2016","unstructured":"Oltmann SC, Alhefdhi AY, Rajaei MH et al (2016) Antiplatelet and anticoagulant medications significantly increase the risk of postoperative hematoma: review of over 4500 thyroid and parathyroid procedures. Ann Surg Oncol 23:2874\u20132882. https:\/\/doi.org\/10.1245\/s10434-016-5241-0","journal-title":"Ann Surg Oncol"},{"key":"2819_CR45","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s00268-019-05322-2","volume":"44","author":"O Edafe","year":"2020","unstructured":"Edafe O, Cochrane E, Balasubramanian SP (2020) Reoperation for bleeding after thyroid and parathyroid surgery: incidence, risk factors, prevention, and management. World journal of surgery 44:1156\u20131162. https:\/\/doi.org\/10.1007\/s00268-019-05322-2","journal-title":"World journal of surgery"},{"key":"2819_CR46","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00423-008-0366-7","volume":"393","author":"A Bergenfelz","year":"2008","unstructured":"Bergenfelz A, Jansson S, Kristoffersson A et al (2008) Complications to thyroid surgery: results as reported in a database from a multicenter audit comprising 3,660 patients. Langenbecks Arch Surg 393:667\u2013673. https:\/\/doi.org\/10.1007\/s00423-008-0366-7","journal-title":"Langenbecks Arch Surg"},{"key":"2819_CR47","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1245\/s10434-014-4283-4","volume":"22","author":"P Riss","year":"2015","unstructured":"Riss P, Kammer M, Selberherr A et al (2015) Morbidity Associated with concomitant thyroid surgery in patients with primary hyperparathyroidism. Ann Surg Oncol 22:2707\u20132713. https:\/\/doi.org\/10.1245\/s10434-014-4283-4","journal-title":"Ann Surg Oncol"},{"key":"2819_CR48","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1001\/archsurg.135.2.142","volume":"135","author":"J Westerdahl","year":"2000","unstructured":"Westerdahl J, Lindblom P, Valdemarsson S et al (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135:142\u2013147. https:\/\/doi.org\/10.1001\/archsurg.135.2.142","journal-title":"Arch Surg"},{"key":"2819_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1089\/thy.2006.16.259","volume":"16","author":"IK McLeod","year":"2006","unstructured":"McLeod IK, Arciero C, Noordzij JP et al (2006) The use of rapid parathyroid hormone assay in predicting postoperative hypocalcemia after total or completion thyroidectomy. Thyroid : official journal of the American Thyroid Association 16:259\u2013265. https:\/\/doi.org\/10.1089\/thy.2006.16.259","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"2819_CR50","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/cen.13476","volume":"88","author":"RM Kaderli","year":"2018","unstructured":"Kaderli RM, Riss P, Geroldinger A et al (2018) Primary hyperparathyroidism: dynamic postoperative metabolic changes. Clinical endocrinology 88:129\u2013138. https:\/\/doi.org\/10.1111\/cen.13476","journal-title":"Clinical endocrinology"},{"key":"2819_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EJE-17-0416","volume":"178","author":"RM Kaderli","year":"2018","unstructured":"Kaderli RM, Riss P, Dunkler D et al (2018) The impact of vitamin D status on hungry bone syndrome after surgery for primary hyperparathyroidism. European journal of endocrinology \/ European Federation of Endocrine Societies 178:1\u20139. https:\/\/doi.org\/10.1530\/EJE-17-0416","journal-title":"European journal of endocrinology \/ European Federation of Endocrine Societies"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-02819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-02819-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-02819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T16:31:33Z","timestamp":1705595493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-02819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,13]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-02819-2","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,13]]},"assertion":[{"value":"3 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Medical University Vienna (EK Number: 1394\/2020) and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All patients must sign a written informed consent for their data to be placed into the EUROCRINE register including any subsequent analyses and publications","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients must sign a written informed consent for their data to be placed into the EUROCRINE register including any subsequent analyses and publications","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"150"}}